Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat

Pain

Volumn 146, Issue 1-2, 2009, Pages 141-147

  Norcini, M ^a   Vivoli, E ^a   Galeotti, N ^a   Bianchi, E ^b   Bartolini, A ^a   Ghelardini, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Behaviour; Hyperalgesia; Kinase; Neuropathic pain; Phosphorylation; PKC

Indexed keywords

BETA ACTIN; CALPHOSTIN C; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXALIPLATIN; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; THALAMUS; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BODY WEIGHT; ENZYME INHIBITORS; HYPERALGESIA; INJECTIONS, INTRAVENTRICULAR; MALE; NAPHTHALENES; ORGANOPLATINUM COMPOUNDS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHORYLATION; PHYSICAL STIMULATION; POSTURAL BALANCE; PRESSURE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 70349770546     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.07.017     Document Type: Article

References (21)

1. Ahlgren S.C., and Levine J.D. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 72 (1994) 684-692
2. Cavaletti G., Tredici G., Petruccioli M.G., Dondè E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M., and Etienne G.G. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 37 (2001) 2457-2463
3. Cersosimo R.J. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39 (2005) 128-135
4. Ciruela A., Dixon A.K., Bramwell S., Gonzalez M.I., Pinnock R.D., and Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br J Pharmacol 138 (2003) 751-756
5. Cliffer K.D., Siuciak J.A., Carson S.R., Radley H.E., Park J.S., Lewis D.R., Zlotchenko E., Nguyen T., Garcia K., Tonra J.R., Stambler N., Cedarbaum J.M., Bodine S.C., Lindsay R.M., and DiStefano P.S. Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol 43 (1998) 46-55
6. Crown E.D., Ye Z., Johnson K.M., Xu G.Y., McAdoo D.J., and Hulsebosch C.E. Increases in the activated forms of ERK1/2, p38MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp Neurol 199 (2006) 397-407
7. Dina O.A., Barletta J., Chen X., Mutero A., Martin A., Messing R.O., and Levine J.D. Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 20 (2000) 8614-8619
8. Fields H.L., and Basbaum A.I. Central nervous system mechanisms of pain modulation. In: Wall P.D., and Melzack R. (Eds). Textbook of pain (1999), Churchill Livingstone, Edinburgh 309-329
9. Gamelin E., Gamelin L., Bossi L., and Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29 (2002) 21-33
10. + channels in neuropathic pain. Expert Opin Investig Drugs 16 (2007) 635-646
11. Joseph E.K., Chen X., Bogen O., and Levine J.D. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9 (2008) 463-472
12. Joseph E.K., and Levine J.D. Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain 10 (2009) 534-541
13. Leighton G.E., Rodriguez R.E., Hill R.G., and Hughes J. Kappa-opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol 93 (1998) 553-560
14. Obata K., Yamanaka H., Dai Y., Mizushima T., Fukuoka T., Tokunaga A., and Noguchi K. Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats. Eur J Neurosci 20 (2004) 2881-2895
15. Paxinos G., and Watson C. The rat brain in stereotaxis coordinates (1982), Academic Press, New York
16. Porreca F., Ossipov M., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci 25 (2002) 319-325
17. Ren K., and Dubner R. Descending modulation in persistent pain: an update. Pain 100 (2002) 1-6
18. Song X.S., Cao J.L., Xu Y.B., He J.H., Zhang L.C., and Zeng Y.M. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neurophatic pain in rats. Acta Pharmacol Sin 26 (2005) 789-798
19. Urban M., and Gebhart G.F. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 69 (1999) 7687-7692
20. Vanegas H., and Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Brain Res Rev 46 (2004) 295-309
21. Vaught J.L., Pelley K., Costa L.G., Setler P., and Enna S.J. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology 24 (1985) 211-216